As a trusted leader in immunology, each new discovery gives us a better understanding of how patients are different - so we can develop more personalized approaches. More than 1 million people with immune-mediated diseases worldwide are treated with our therapies.
How AbbVie is working to elevate the standards of care for patients with autoimmune diseases
Could precision medicine help immunology patients the way it has helped cancer patients?
A diagnosis at 13 years old, Marisa Troy’s life and her aspirations were greatly impacted by her IBD.
One person with psoriasis shares her journey — from childhood to working parent — and how her struggles with the disease have empowered her.
Science is working to uncover the roots of this serious inflammatory disease.
After a long journey to diagnosis, one patient finds strength in advocating for herself and others.
Creative problem solving and data-driven science helps researchers illuminate a smarter path toward compounds that may address unmet patient needs.
An invisible illness, Crohn’s disease impacts the patient and those closest to them. One patient shares how the love of her life helps her thrive every day.
How do new medicines originate? Meet the team behind early development of AbbVie’s immunology treatments.
Bruton’s tyrosine kinase helps immune function, but its malfunction may lead to cancer and autoimmune diseases. Scientists are researching new approaches in both areas.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?